Innoviva, Inc.INVANASDAQ
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank69
5Y CAGR-1.9%
Studio
Year-over-Year Change

Year-over-year net income growth rate

5Y CAGR
-1.9%/yr
Long-term compound
Percentile
P69
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 202582.58%
Q3 202541.17%
Q2 2025236.72%
Q1 2025-329.12%
Q4 20241576.17%
Q3 2024103.50%
Q2 2024-194.94%
Q1 2024-40.63%
Q4 2023-25.00%
Q3 20236309.84%
Q2 2023-96.33%
Q1 2023151.04%
Q4 2022-125.73%
Q3 202228177.21%
Q2 2022-94.05%
Q1 202252.47%
Q4 2021-85.72%
Q3 2021-18.56%
Q2 2021-5.50%
Q1 202174.62%
Q4 202091.02%
Q3 2020-63.28%
Q2 202017.43%
Q1 202042.41%
Q4 201915.42%
Q3 20195.48%
Q2 201911.69%
Q1 2019-87.19%
Q4 2018460.13%
Q3 2018-13.80%
Q2 201884.67%
Q1 2018-49.33%
Q4 2017145.66%
Q3 2017-32.38%
Q2 2017108.64%
Q1 2017-33.86%
Q4 201669.43%
Q3 20162.99%
Q2 2016229.13%
Q1 20163.12%